Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Oct 6, 2026
Filed with the SEC on Oct 6, 2026 and accepted by EDGAR at Oct 6, 2026, 07:51 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.02 Results of operations
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-26-113895. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.